EPB41L1: A Protein Involved in Disease Development (G2036)

Target Name: EPB41L1

NCBI ID: G2036

EPB41L1

EPB41L1: A Protein Involved in Disease Development

EPB41L1 (KIAA0338) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the E-cadherin family, which is a group of transmembrane proteins that play a role in cell-cell adhesion.

One of the unique features of EPB41L1 is its ability to interact with the protein PDGF-BB, which is a key signaling molecule in the development and maintenance of tissues. This interaction between EPB41L1 and PDGF-BB has led to the conclusion that EPB41L1 may be a drug target or biomarker for various diseases.

EPB41L1 has been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. For example, studies have shown that high levels of EPB41L1 are associated with poor prognosis in patients with pancreatic cancer, and that decreased levels of EPB41L1 are associated with increased risk of developing heart disease.

In addition to its potential as a drug target or biomarker, EPB41L1 is also of interest as a potential therapeutic target for treating certain neurological disorders. For example, studies have shown that EPB41L1 is involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. Therefore, targeting EPB41L1 with drugs or other therapeutic agents may be a promising approach to treating these disorders.

In conclusion, EPB41L1 is a protein that has been shown to play a role in the development and progression of various diseases. Its interaction with PDGF-BB and its association with cancer, neurodegenerative diseases, and cardiovascular diseases make it an attractive target for drug development. Further research is needed to fully understand the role of EPB41L1 in these diseases and to develop effective therapies that target this protein.

Protein Name: Erythrocyte Membrane Protein Band 4.1 Like 1

Functions: May function to confer stability and plasticity to neuronal membrane via multiple interactions, including the spectrin-actin-based cytoskeleton, integral membrane channels and membrane-associated guanylate kinases

The "EPB41L1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EPB41L1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets